Publication | Open Access
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
50
Citations
32
References
2018
Year
Rasagiline did not alter disease progression compared with controls over 12 months of treatment. Muscle Nerve 59:201-207, 2019.
| Year | Citations | |
|---|---|---|
Page 1
Page 1